Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carroll

Showing results (1401-1410 of 1,449) with videos related to

Pageof 145
Sort By:
Cancer Discovery|January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor GrowthHubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
FEBS Letters|July 9, 2013
A model of yeast glycolysis based on a consistent kinetic characterisation of all its enzymesKieran Smallbone, Hanan L Messiha, Kathleen M Carroll, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
The EMBO Journal|February 6, 2016
Mitochondria are required for pro-ageing features of the senescent phenotypeClara Correia-Melo, Francisco D M Marques, Rhys Anderson, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Nature|June 22, 2022
Biosynthetic potential of the global ocean microbiomeLucas Paoli, Hans-Joachim Ruscheweyh, Clarissa C Forneris, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
The Lancet. Neurology|December 26, 2017
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J Thompson, Brenda L Banwell, Frederik Barkhof, et al.
Cancer Cell|July 11, 2023
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinomaThomas M Carroll, Joseph A Chadwick, Richard P Owen, et al.
Pageof 145

Showing results (1401-1410 of 1,449) with videos related to

Sort By:
Pageof 145
Cancer Discovery|January 28, 2021
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor GrowthHubert Lam, Lisa K McNeil, Hanna Starobinets, et al.
FEBS Letters|July 9, 2013
A model of yeast glycolysis based on a consistent kinetic characterisation of all its enzymesKieran Smallbone, Hanan L Messiha, Kathleen M Carroll, et al.
BMJ Neurology Open|December 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trialKayla Ward, Vivien Li, Sudarshini Ramanathan, et al.
The EMBO Journal|February 6, 2016
Mitochondria are required for pro-ageing features of the senescent phenotypeClara Correia-Melo, Francisco D M Marques, Rhys Anderson, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Drug and Alcohol Dependence|May 4, 2020
The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agendaMallory J E Loflin, Brian D Kiluk, Marilyn A Huestis, et al.
Nature|June 22, 2022
Biosynthetic potential of the global ocean microbiomeLucas Paoli, Hans-Joachim Ruscheweyh, Clarissa C Forneris, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
The Lancet. Neurology|December 26, 2017
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J Thompson, Brenda L Banwell, Frederik Barkhof, et al.
Cancer Cell|July 11, 2023
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinomaThomas M Carroll, Joseph A Chadwick, Richard P Owen, et al.
Pageof 145